Summary
Alison John is a cell & molecular biologist investigating why some individuals respond to lung injury by developing progressive pulmonary fibrosis while others heal without evidence of scarring and using that knowledge to develop new anti-fibrotic therapies. She is an Advanced Research Fellow in the Margaret Turner Warwick Centre for Fibrosing Lung Diseases at the National Heart and Lung Institute.
Publications
Journals
Goodwin AT, John AE, Joseph C, et al., 2023, Stretch regulates alveologenesis and homeostasis via mesenchymal Gαq/11-mediated TGFβ2 activation, Development, Vol:150, ISSN:0950-1991
Stephenson KE, Porte J, Kelly A, et al., 2023, The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis, Respiratory Research, Vol:24, ISSN:1465-9921
Tatler AL, Philp CJ, Hill MR, et al., 2023, Differential remodeling in small and large murine airways revealed by novel whole lung airway analysis., American Journal of Physiology: Lung Cellular and Molecular Physiology, Vol:324, ISSN:1040-0605, Pages:L271-L284
Conference
Jimenez ELL, Bin Liu K, Zarcone MC, et al., 2023, Functional Screening in Lung Epithelial Cells and Fibroblast of Novel and Known Genetic Associations With Idiopathic Pulmonary Fibrosis, International Conference of the American-Thoracic-Society (ATS), AMER THORACIC SOC, ISSN:1073-449X
Calver JF, Harris G, Lithgo R, et al., 2022, Investigating the pro-fibrotic effects of galectins in idiopathic pulmonary fibrosis - a potential role for glycan-mediated interactions with integrins, American Thoracic Society 2022 International Conference, American Thoracic Society, Pages:1-1, ISSN:1073-449X